News
Last update: Thursday January 29, 2026
Journal of the American College of Cardiology advances
Patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) suffer substantial morbidity and mortality. The meaningful preservation of functional capacity and quality of life...
Original:  Benefits of Patisiran on Functional Capacity in ATTR Cardiac Amyloidosis Post Hoc...
Author(s): Berk, John L. et al.
 
Amyloid
Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a progressive fatal disorder caused by deposition of mutant transthyretin (TTR) amyloids mainly in the nerves...
Original:  Altered connectivity of central autonomic network: effects of dysautonomia in hereditary...
Author(s): Tsai-Jou Su a et al.

Search Bibliographic  
396
available articles

Search by journal
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
 
Search by topic
Clinical news | Archives


REACT TO CURRENT EVENTS.
Has an article caught your attention? Send the abstract along with your comments to a colleague.
Click on the "Share this article" link and share your comments on the news.

   Top articles  


Journal of the American College of Cardiology advances
Benefits of Patisiran on Functional Capacity in ATTR...  | Berk, John L. et al.
Patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) suffer substantial morbidity and mortality. The meaningful...
Expert Opinion on Pharmacotherapy
Amyloidosis of the heart: pathophysiology, diagnosis,...  | Andy Wang et al.
Cardiac amyloidosis is characterized by amyloid fibril aggregation due to misfolded circulating proteins and their deposition...
Cardio-Oncology
Increasing clinicians’ suspicion of ATTR amyloidosis...  | Ammon Jessica et al.
Amyloidosis is a disease characterized by extracellular tissue deposition of insoluble fibrils composed of abnormally folded...
Newsletter
Check out the latest publications shared through our dedicated newsletter.

Congresses agenda
Stay informed about the latest medical advancements in your area of expertise.


About the service
Exclusive access to the latest scientific publications from reputable medical journals.
Member area
Login

This bibliographical database is provided by GNM Healthcare Consulting France SAS in full editorial independence. The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
The information disseminated as part of this service may discuss or suggest certain therapies that are not approved by the Marketing Authorization (AMM).

With the institutional support of